MA37533A1 - Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents

Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Info

Publication number
MA37533A1
MA37533A1 MA37533A MA37533A MA37533A1 MA 37533 A1 MA37533 A1 MA 37533A1 MA 37533 A MA37533 A MA 37533A MA 37533 A MA37533 A MA 37533A MA 37533 A1 MA37533 A1 MA 37533A1
Authority
MA
Morocco
Prior art keywords
oregano
essential oil
antibacterial effect
actinomycetemcomitans
aaggregatibacter
Prior art date
Application number
MA37533A
Other languages
French (fr)
Other versions
MA37533B1 (en
Inventor
Leila Lakhdar
Abdellah Farah
Abdellah Ennibi Oumkeltoum Farah
Original Assignee
Université Mohammed V De Rabat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Mohammed V De Rabat filed Critical Université Mohammed V De Rabat
Priority to MA37533A priority Critical patent/MA37533B1/en
Priority to PCT/MA2014/000037 priority patent/WO2016076686A1/en
Publication of MA37533A1 publication Critical patent/MA37533A1/en
Publication of MA37533B1 publication Critical patent/MA37533B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Abstract

L’application de |'effet antibactérien de l'huile essentielle d’origan (origanum compactum) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n’a jamais fait l’objet de tests antimicrobiens à base d’huiles essentielles.Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of oregano (origanum compactum) of Moroccan origin on a virulent oral bacterial strain; aggregatibacter actinomycetemcomitans clone jp2. This original strain has never been the subject of antimicrobial tests based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.

MA37533A 2014-11-13 2014-11-13 Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans MA37533B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA37533A MA37533B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
PCT/MA2014/000037 WO2016076686A1 (en) 2014-11-13 2014-11-27 Pharmacological composition of oregano (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA37533A MA37533B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Publications (2)

Publication Number Publication Date
MA37533A1 true MA37533A1 (en) 2016-06-30
MA37533B1 MA37533B1 (en) 2017-01-31

Family

ID=52574401

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37533A MA37533B1 (en) 2014-11-13 2014-11-13 Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans

Country Status (2)

Country Link
MA (1) MA37533B1 (en)
WO (1) WO2016076686A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119169B2 (en) * 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
US8858970B2 (en) * 2011-01-13 2014-10-14 Austin Research Labs Corp. High load dispersions

Also Published As

Publication number Publication date
WO2016076686A1 (en) 2016-05-19
MA37533B1 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
CL2020001048A1 (en) Monoclonal antibodies against bcma. (divisional request 201800281)
AR106768A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES
MA46109A (en) HIGH CONCENTRATE, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS
NZ725569A (en) Lubricant formulations
CL2020001391A1 (en) Lyophilized formulation of a monoclonal antibody against transthyretin.
AR108546A1 (en) COMPOSITIONS, KITS AND METHODS FOR WEED CONTROL
CO2022017690A2 (en) Antibodies against sars-cov-2 and methods of selection and use thereof
AR111099A1 (en) USE OF A SERUM FOR CLOTHING WASHING
MX2021006977A (en) Anellosomes and methods of use.
FR3097125B1 (en) Coloring composition comprising a combination of two plant extracts of Lawsonia inermis
MA37533B1 (en) Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37532A1 (en) Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37530A1 (en) Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans
MA37534A1 (en) Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
MA37529A1 (en) Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans.
MA37531A1 (en) Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans
BR102019017344A8 (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE
BR112017018618A2 (en) osmanthus odorant
AR112996A1 (en) ANTIBODY-DRUG CONJUGATE EVALUATION METHODS
CL2018002949A1 (en) Compositions for oral care.
MA49960A (en) HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME
CL2018000568A1 (en) Feed composition for the prevention and treatment of parasitic fish infection
FR3053891B1 (en) DIFFUSER OF VAPORS, IN PARTICULAR ESSENTIAL OILS
PL428239A1 (en) Alcohol composition, application of essential hemp oil and application of hemp panicle extract for preparing the alcohol composition
FR3090374B1 (en) Nail care based on vegetable taurine